Zackery P Bulman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Zackery P Bulman

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Antimicrobial Agents and Chemotherapy|August 4, 2022

Mechanistic Insights to Combating NDM- and CTX-M-Coproducing Klebsiella pneumoniae by Targeting Cell Wall Synthesis and Outer Membrane IntegrityNicholas M Smith, Katie Rose Boissonneault, Liang Chen, et al.

Ebiomedicine|January 1, 2026

Multicentre preclinical profiling of apramycin for the treatment of nontuberculous mycobacteriaMinh-Vu H Nguyen, Michel Plattner, Deepshikha Verma, et al.

Nature Communications|December 2, 2023

Klebsiella pneumoniae clinical isolates with features of both multidrug-resistance and hypervirulence have unexpectedly low virulenceTravis J Kochan, Sophia H Nozick, Aliki Valdes, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Antimicrobial Agents and Chemotherapy|August 4, 2022

Ebiomedicine|January 1, 2026

Multicentre preclinical profiling of apramycin for the treatment of nontuberculous mycobacteriaMinh-Vu H Nguyen, Michel Plattner, Deepshikha Verma, et al.

Nature Communications|December 2, 2023

Klebsiella pneumoniae clinical isolates with features of both multidrug-resistance and hypervirulence have unexpectedly low virulenceTravis J Kochan, Sophia H Nozick, Aliki Valdes, et al.

Pageof 6